Purple Biotech Ltd ADR
(PPBT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 11,005 | 22,271 | 22,603 | 17,934 | 13,239 |
| Operating Income | -11,005 | -22,271 | -22,603 | -17,934 | -13,239 |
| Interest Expense | 483 | 2,195 | 67 | 212 | 61 |
| Other Income | 4,209 | 4,489 | 910 | 320 | -15,401 |
| Pre-tax Income | -7,279 | -19,977 | -21,760 | -17,826 | -28,701 |
| Net Income Continuous | -7,279 | -19,977 | -21,760 | -17,826 | -28,701 |
| Net Income Discontinuous | N/A | N/A | N/A | -642 | 627 |
| Minority Interests | -39 | -97 | -92 | -84 | -75 |
| Net Income | $-7,240 | $-19,880 | $-21,668 | $-18,384 | $-27,999 |
| EPS Basic Total Ops | -4.44 | -17.96 | -24.00 | -20.20 | -49.00 |
| EPS Basic Continuous Ops | -4.44 | -18.05 | -24.07 | -20.29 | -49.91 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.73 | 1.09 |
| EPS Diluted Total Ops | -4.99 | -17.96 | -24.00 | -20.20 | -49.00 |
| EPS Diluted Continuous Ops | -4.44 | -18.05 | -24.07 | -20.29 | -49.91 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.73 | 1.09 |
| EPS Diluted Before Non-Recurring Items | -4.99 | -21.80 | -21.60 | -20.20 | -21.60 |
| EBITDA(a) | $-10,819 | $-22,074 | $-22,402 | $-17,703 | $-13,004 |